Inflation And COVID Putting Pressure On Europe’s Paracetamol Supply Chain
Executive Summary
Inflation, new COVID-19 waves and delayed cold and flu outbreaks are causing disruption to Europe's paracetamol supply chain, according to an investigation by HBW Insight. Industry is not currently concerned, but regulators, for example in France, are introducing measures to prevent this issue spreading from children's to adult forms of the drug, as well as to ibuprofen-based alternatives.
You may also be interested in...
Paracetamol Included In EU List Of Critical Medicines
Paracetamol makes it onto the European Commission's first ever EU-level list of critical medicines whose continuity of supply is a priority and for which “shortages should be avoided.”
France’s Gemme Claims A Victory With Price-Cut Reversal
French generics industry association Gemme has claimed a major victory in shifting the country’s policy on generic price cuts, after the government announced a moratorium on price reductions as well as targeted price increases for certain key locally-produced generics.
Euro Q4 Consumer Health Earnings Preview: Sanofi, Bayer, Reckitt And Haleon
Major Europe-based consumer health players Sanofi Bayer, Reckitt and Haleon feature in this sales and earnings preview, which highlights what to look out for as these four firms report their Q4 2022 results over the coming weeks.